FGFR1, a novel biomarker for metastatic castration-resistant prostate cancer?
FGFR1, a novel biomarker for metastatic castration-resistant prostate cancer? |
|
https://doi.org/10.18632/oncotarget.27957
Leandro H. Gallo
|
| 1026-1028 |
Advances in innovative exosome-technology for real time monitoring of viable drugs in clinical translation, prognosis and treatment response
Advances in innovative exosome-technology for real time monitoring of viable drugs in clinical translation, prognosis and treatment response |
|
https://doi.org/10.18632/oncotarget.27927
Mujib Ullah,
Nicole Pek Min Qian,
and Gustavo Yannarelli
|
| 1029-1031 |
Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting?
Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting? |
|
https://doi.org/10.18632/oncotarget.27931
Alexander J. Bridges,
Ranjit K. Mehta,
Sushmita Shukla,
Matthew J. Schipper,
Theodore S. Lawrence,
and Mukesh K. Nyati
|
| 1032-1036 |
CEA as a blood-based biomarker in anal cancer
CEA as a blood-based biomarker in anal cancer |
|
https://doi.org/10.18632/oncotarget.27959
Robert Hester,
Shailesh Advani,
Asif Rashid,
Emma Holliday,
Craig Messick,
Prajnan Das,
Yi-Qian N. You,
Cullen Taniguchi,
Eugene J. Koay,
Brian Bednarski,
Miguel Rodriguez-Bigas,
John Skibber,
Robert Wolff,
George J. Chang,
Bruce D. Minsky,
Wai Chin Foo,
Nicole Rothschild,
Van K. Morris,
and Cathy Eng
|
| 1037-1045 |
Occurence of RAS reversion in metastatic colorectal cancer patients treated with bevacizumab
Occurence of RAS reversion in metastatic colorectal cancer patients treated with bevacizumab |
|
https://doi.org/10.18632/oncotarget.27965
Samantha Epistolio,
Marco Cefalì,
Paolo Spina,
Francesca Molinari,
Alessandra Movilia,
Massimiliano Cergnul,
Luca Mazzucchelli,
Sara De Dosso,
Milo Frattini,
and Piercarlo Saletti
|
| 1046-1056 |
Caspase-11 and AIM2 inflammasome are involved in smoking-induced COPD and lung adenocarcinoma
Caspase-11 and AIM2 inflammasome are involved in smoking-induced COPD and lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.27964
Chiara Colarusso,
Michela Terlizzi,
Anne-Sophie Lamort,
Ida Cerqua,
Fiorentina Roviezzo,
Georgios Stathopoulos,
Aldo Pinto,
and Rosalinda Sorrentino
|
| 1057-1071 |
A novel E2F1-regulated lncRNA, LAPAS1, is required for S phase progression and cell proliferation
A novel E2F1-regulated lncRNA, LAPAS1, is required for S phase progression and cell proliferation |
|
https://doi.org/10.18632/oncotarget.27962
Esther Baruch,
Tali Nizri-Megnaji,
Oron Berkowitz,
and Doron Ginsberg
|
| 1072-1082 |
Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network
Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network |
|
https://doi.org/10.18632/oncotarget.27963
Shweta Kishor Sonawane,
and Subashchandrabose Chinnathambi
|
| 1083-1099 |
Ex vivo analysis of DNA repair targeting in extreme rare cutaneous apocrine sweat gland carcinoma
Ex vivo analysis of DNA repair targeting in extreme rare cutaneous apocrine sweat gland carcinoma |
|
https://doi.org/10.18632/oncotarget.27961
Rami Mäkelä,
Ville Härmä,
Nibal Badra Fajardo,
Greg Wells,
Zoi Lygerou,
Olle Sangfelt,
Juha Kononen,
and Juha K. Rantala
|
| 1100-1109 |
Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment
Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment |
|
https://doi.org/10.18632/oncotarget.27929
Khoa Nguyen,
Andrew Rivera,
Madlin Alzoubi,
Henri Wathieu,
Shengli Dong,
Hassan Yousefi,
Margarite Matossian,
Suresh Alahari,
David Drewry,
Matthew Burow,
and Bridgette Collins-Burow
|
| 1110-1115 |
Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review |
|
https://doi.org/10.18632/oncotarget.27966
Marco Rubatto,
Martina Merli,
Gianluca Avallone,
Andrea Agostini,
Luca Mastorino,
Virginia Caliendo,
Amelia Barcellini,
Viviana Vitolo,
Francesca Valvo,
Maria Teresa Fierro,
Simone Ribero,
and Pietro Quaglino
|
| 1116-1121 |
